GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWY) » Definitions » 5-Year Share Buyback Ratio

CZMWY (Carl Zeiss Meditec AG) 5-Year Share Buyback Ratio : 0.30% (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Carl Zeiss Meditec AG 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Carl Zeiss Meditec AG's current 5-Year Share Buyback Ratio was 0.30%.

CZMWY's 5-Year Share Buyback Ratio is ranked better than
90.25% of 667 companies
in the Medical Devices & Instruments industry
Industry Median: -4.4 vs CZMWY: 0.30

Competitive Comparison of Carl Zeiss Meditec AG's 5-Year Share Buyback Ratio

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carl Zeiss Meditec AG's 5-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's 5-Year Share Buyback Ratio falls into.


;
;

Carl Zeiss Meditec AG 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Carl Zeiss Meditec AG (OTCPK:CZMWY) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Carl Zeiss Meditec AG 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Carl Zeiss Meditec AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWY) » Definitions » 5-Year Share Buyback Ratio
Comparable Companies
XTER:FIE XTER:1SXP XTER:GXI ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN COO BAX WST ALGN HOLX NZSE:FPH SOLV
Traded in Other Exchanges
CZMWF:USA 1AFX:Italy AFXd:UK 0DHC:UK AFX:Germany AFX:Bulgaria AFX:Austria
Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Website
https://www.zeiss.com
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.